Madhi SA, Kwatra G, Myers JE, Jassat W, Dhar N, Mukendi CK, et al. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa. N Engl J Med. 2022;386(14):1314-26.
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
By Peter Matlawa|2022-06-06T23:20:24+02:00June 6, 2022|2022 Publication, 2022: January to March|Comments Off on Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Recency of HIV infection, antiretroviral therapy use and viral loads among symptomatic sexually transmitted infection service attendees in South Africa